Name: Polyhydroxyalkanoate (PHA) Market by Type (Short Chain Length, Medium Chain Length), Production Method (Sugar Fermentation, Vegetable Oil Fermentation), Application (Packaging & Food Services, Biomedical), and Region - Global Forecasts to 2030
Brand: MarketsandMarkets
SKU: CH1610
Price: 4950 USD
Availability: InStock

報告摘要

The polyhydroxyalkanoate (PHA) market size was USD 123.8 million in 2025 and is projected to reach USD 265.2 million by 2030, at a CAGR of 16.5% between 2025 and 2030. “Regulatory pressure and sustainability mandates to accelerate PHA market growth” Strict global policies against plastic waste and the use of fossil-based substances are a major driver of the PHA market. Governments are also taking actions such as banning single-use plastic, encouraging bio-based polymers, and making compostability mandatory, which provide a regulatory push towards PHAs. Such policies have been especially significant in areas like packaging, consumer goods, agriculture, and biomedical applications, where adherence to environmental and safety standards is becoming a prerequisite. Brands are being pressurized to enhance sustainability activities and are compelled to implement PHAs to achieve corporate ESG goals. These regulatory and corporate sustainability requirements are providing a boost to the transition to PHA-based solutions in industries. “Agriculture sector to account for third-largest market share during forecast period“ In 2024, the agriculture sector accounted for the third-largest share in the overall PHA market. The increase in demand for biodegradable and soil-safe materials in agricultural activities is driving the market in this application. As there is an ongoing shift toward sustainability and regulatory standards, PHA is being implemented in mulch films, plant pots, seed coatings, and controlled-release fertilizers by manufacturers who are avoiding the use of conventional plastics. Its biodegradation in soil saves waste-management expense and reduces environmental impact. Moreover, government incentives for the use of environmentally friendly farm inputs also speed up adoption. “Short chain length segment projected to be fastest-growing type of PHA during forecast period” The short chain length PHA segment is estimated to be the fastest-growing type, in terms of value, during the forecast period. Short chain length PHA is more mechanically strong, more crystalline, and applicable in a wide range of packaging, agriculture, and biomedical products. Its performance properties resemble traditional plastics and, hence, is a suitable alternative in industries that are rapidly moving towards biodegradable products. The intense regulatory pressure to minimize the consumption of fossil-based plastics further boosts the demand for short chain length PHA. Moreover, the expansion of production capacities and enhancement of cost structures are facilitating increased commercial usage. “Asia Pacific accounted for third-largest share of global PHA market, in terms of value, in 2024” Asia Pacific is the third-largest PHA market in 2024. The market in the region is driven by the increase in demand for biodegradable materials in the packaging, agriculture, and consumer goods applications. Increasing regulatory intervention with single-use plastics in China, Japan, India, and South Korea is creating a motivating push towards PHA-based products. The region’s market is also supported by a growing biopolymer production base and a high level of government attention toward the circular economy. The growing consumer interest in sustainable materials, as well as the booming development of e-commerce packaging, further supports the market growth. • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20% • By Designation: Directors - 50%, Managers - 30%, and Others - 20% • By Region: North America - 40%, Europe - 35%, Asia Pacific - 20%, RoW– 5% The key players profiled in the report include Teknor Apex (US), Kaneka Corporation (Japan), Ecomann Biotechnology Co., Ltd. (China), RWDC Industries (Singapore), Bluepha Co., Ltd. (China), Newlight Technologies, Inc. (US), Ningbo Tianan Biologic Materials Co., Ltd. (China), Biomer (Germany), Beijing PhaBuilder Biotechnology Co., Ltd. (China), and TerraVerdae Bioworks Inc. (Canada). Study Coverage This report segments the market for PHA based on type, production method, application, and region, and provides estimations of value (in USD Million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the PHA market. Reasons to Buy this Report This research report is focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the PHA market, high-growth regions, and market drivers, restraints, and opportunities. The report provides insights into the following points: • Market Penetration: Comprehensive information on PHA offered by top players in the global market • Analysis of key drivers: (Green procurement policies, High availability of renewable and cost-effective raw materials, Biodegradability driving consumption, Increasing concerns about human health and safety), restraints (High price compared to conventional polymers and Performance issues), opportunities (Increasing scope in end-use segments, Emergence of new raw materials, Cyanobacteria enabling cost reduction, and Growth opportunities in Asia Pacific) and challenges (Manufacturing technology in initial phase and Expensive and complex production process) influencing the growth of PHA market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the PHA market • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the market for PHA across regions. • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global PHA market • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the PHA market

目錄 Table of Contents

1 INTRODUCTION 22 1.1 STUDY OBJECTIVES 22 1.2 MARKET DEFINITION 22 1.3 STUDY SCOPE 23 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 23 1.3.2 INCLUSIONS AND EXCLUSIONS OF STUDY 23 1.3.3 MARKET DEFINITION AND INCLUSIONS, BY TYPE 24 1.3.4 MARKET DEFINITION AND INCLUSIONS, BY PRODUCTION METHOD 24 1.3.5 MARKET DEFINITION AND INCLUSIONS, BY APPLICATION 24 1.3.6 YEARS CONSIDERED 25 1.3.7 CURRENCY CONSIDERED 25 1.3.8 UNIT CONSIDERED 25 1.4 STAKEHOLDERS 25 1.5 SUMMARY OF CHANGES 26 2 EXECUTIVE SUMMARY 27 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 27 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 29 2.3 DISRUPTIVE TRENDS SHAPING MARKET 30 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 30 2.5 SNAPSHOT: EUROPE MARKET SIZE, GROWTH RATE, AND FORECAST 31 3 PREMIUM INSIGHTS 33 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHA MARKET 33 3.2 PHA MARKET, BY APPLICATION AND REGION 34 3.3 PHA MARKET, BY TYPE 34 3.4 PHA MARKET, BY COUNTRY 35 4 MARKET OVERVIEW 36 4.1 INTRODUCTION 36 4.2 MARKET DYNAMICS 36 4.2.1 DRIVERS 37 4.2.1.1 Green procurement policies 37 4.2.1.2 High availability of renewable and cost-effective raw materials 38 4.2.1.3 Biodegradability driving consumption 39 4.2.1.4 Increasing concerns about human health and safety 39 4.2.2 RESTRAINTS 42 4.2.2.1 Higher price of PHA than conventional polymers 42 4.2.2.2 Performance issues 42 4.2.3 OPPORTUNITIES 42 4.2.3.1 Increasing scope in end-use segments 42 4.2.3.2 Emergence of new raw materials 43 4.2.3.3 Cyanobacteria enabling cost reduction 43 4.2.3.4 Growth opportunities in Asia Pacific 43 4.2.4 CHALLENGES 44 4.2.4.1 Manufacturing technology in initial phase 44 4.2.4.2 Expensive and complex production process 44 4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 44 4.3.1 INTERCONNECTED MARKETS 44 4.3.2 CROSS-SECTOR OPPORTUNITIES 45 4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 45 4.4.1 KEY MOVES AND STRATEGIC FOCUS 45 5 INDUSTRY TRENDS 46 5.1 PORTER'S FIVE FORCES ANALYSIS 46 5.1.1 THREAT OF SUBSTITUTES 46 5.1.2 THREAT OF NEW ENTRANTS 47 5.1.3 BARGAINING POWER OF SUPPLIERS 47 5.1.4 BARGAINING POWER OF BUYERS 47 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 47 5.2 MACROECONOMIC INDICATORS 48 5.2.1 INTRODUCTION 48 5.2.2 GDP TRENDS AND FORECAST FOR MAJOR ECONOMIES 48 5.2.3 TRENDS IN GLOBAL PACKAGING INDUSTRY 50 5.3 SUPPLY CHAIN ANALYSIS 50 5.4 ECOSYSTEM ANALYSIS 52 5.5 PRICING ANALYSIS 55 5.5.1 AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 55 5.5.2 AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025 56 5.6 TRADE ANALYSIS 56 5.6.1 IMPORT SCENARIO (HS CODE 391190) 57 5.6.2 EXPORT SCENARIO (HS CODE 391190) 58 5.7 KEY CONFERENCES & EVENTS IN 2025–2026 59 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 59 5.9 INVESTMENT AND FUNDING SCENARIO 60 5.10 CASE STUDY ANALYSIS 61 5.10.1 BACARDI TRANSITIONS FROM PET TO DANIMER SCIENTIFIC’S BIODEGRADABLE PHA BOTTLES FOR SUSTAINABLE PACKAGING 61 5.10.2 SHISEIDO COMPANY LTD. ADOPTS PHBH BIOPOLYMER FOR COSMETICS PACKAGING 61 5.11 IMPACT OF 2025 US TARIFF – PHA MARKET 61 5.11.1 INTRODUCTION 61 5.11.2 KEY TARIFF RATES 62 5.11.3 PRICE IMPACT ANALYSIS 63 5.11.4 IMPACT ON COUNTRY/REGION 63 5.11.4.1 US 63 5.11.4.2 Europe 64 5.11.4.3 Asia Pacific 64 5.11.5 IMPACT ON APPLICATIONS 65 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, AND PATENTS 67 6.1 KEY EMERGING TECHNOLOGIES 67 6.1.1 SYNTHETIC BIOLOGY AND STRAIN ENGINEERING 67 6.1.2 CONTINUOUS AND HIGH-DENSITY BIOREACTORS 67 6.1.3 PHA BLENDS AND COPOLYMERS 67 6.2 COMPLEMENTARY TECHNOLOGIES 68 6.2.1 DOWNSTREAM PURIFICATION TECHNOLOGIES 68 6.2.2 COMPOSTING & BIODEGRADATION TECHNOLOGIES 68 6.3 TECHNOLOGY/PRODUCT ROADMAP 68 6.3.1 SHORT-TERM (2025–2027) | PRODUCTION SCALE-UP & COST REDUCTION 68 6.3.2 MID-TERM (2027–2030) | PERFORMANCE ENHANCEMENT & APPLICATION EXPANSION 69 6.3.3 LONG-TERM (2030–2035+) | SUSTAINABILITY & CIRCULARITY 69 6.4 PATENT ANALYSIS 70 6.4.1 APPROACH 70 6.4.2 DOCUMENT TYPE 70 6.4.3 TOP APPLICANTS 73 6.4.4 JURISDICTION ANALYSIS 75 6.5 IMPACT OF AI/GEN AI ON PHA MARKET 75 6.5.1 ACCELERATED R&D AND FORMULATION INNOVATION 76 6.5.2 ENHANCED PRODUCTION EFFICIENCY AND PROCESS CONTROL 76 6.5.3 PREDICTIVE MAINTENANCE AND OPERATIONAL CONTINUITY 76 6.5.4 OPTIMIZED SUPPLY CHAIN AND COST MANAGEMENT 76 6.5.5 SUSTAINABILITY MODELING AND LIFE CYCLE OPTIMIZATION 76 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 77 7.1 REGIONAL REGULATIONS AND COMPLIANCE 77 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 7.1.2 INDUSTRY STANDARDS 79 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 80 7.2.1 SAFETY PROTOCOLS 80 7.2.2 SUSTAINABLE DEVELOPMENT 80 7.2.3 STANDARDIZATION 80 7.2.4 CIRCULAR ECONOMY 80 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 81 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 82 8.1 DECISION-MAKING PROCESS 82 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 83 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 8.2.2 BUYING CRITERIA 83 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 84 8.4 UNMET NEEDS IN VARIOUS APPLICATIONS 85 9 SOURCES AND PROCESSES OF PHA PRODUCTION 87 9.1 GENERAL PRODUCTION PROCESS 87 9.2 SUGAR SUBSTRATE OR CARBOHYDRATES FROM PLANTS 87 9.3 TRIACYLGLYCEROLS 88 9.4 HYDROCARBONS 89 9.5 STRAIN SELECTION 89 9.6 BIOPROCESS AND DOWNSTREAM PROCESS 91 9.6.1 FERMENTATION PROCESS 91 9.6.1.1 Discontinuous process 91 9.6.1.1.1 Batch process 91 9.6.1.1.2 Fed-batch process 91 9.6.1.1.3 Fed-batch process with cell recycling 91 9.6.1.1.4 Repeated fed-batch 91 9.6.1.2 Continuous process 91 9.6.1.2.1 Continuous fed-batch process 91 9.6.1.2.2 One-stage chemostat 92 9.6.1.2.3 Two-stage chemostat 92 9.6.1.2.4 Multi-stage chemostat 92 9.6.2 EXTRACTION PROCESS 92 10 PRODUCTION CAPACITY ANALYSIS 93 11 PHA MARKET, BY TYPE 96 11.1 INTRODUCTION 97 11.2 SHORT CHAIN LENGTH 99 11.2.1 EXCELLENT PHYSICAL AND MECHANICAL PROPERTIES TO DRIVE MARKET 99 11.2.2 POLYHYDROXYVALERATE (PHV) 99 11.2.3 P (4HB-CO-3HB) 99 11.2.4 P (3HB-CO-3HV) 99 11.2.5 OTHERS 99 11.3 MEDIUM CHAIN LENGTH 101 11.3.1 EXPANDING APPLICATION NEEDS IN BIOMEDICAL AND PACKAGING SECTORS PROPEL MARKET GROWTH 101 11.3.2 P (HYDROXYBUTYRATE-CO-HYDROXYOCTANOATE) 101 11.3.3 P (3HB-CO-3HV-CO-4HB) 101 11.3.4 OTHERS 101 12 PHA MARKET, BY PRODUCTION METHOD 103 12.1 INTRODUCTION 104 12.2 SUGAR FERMENTATION 105 12.2.1 AVAILABILITY OF LOW-COST CARBOHYDRATE FEEDSTOCKS TO BOOST DEMAND 105 12.3 VEGETABLE OIL FERMENTATION 106 12.3.1 STRENGTHENING CIRCULAR ECONOMY POLICIES ACCELERATING MARKET ADOPTION 106 12.4 METHANE FERMENTATION 106 12.4.1 EXPANDING WASTE-GAS UTILIZATION AND CARBON-REDUCTION MANDATES ACCELERATING MARKET GROWTH 106 13 PHA MARKET, BY APPLICATION 107 13.1 INTRODUCTION 108 13.2 PACKAGING & FOOD SERVICES 110 13.2.1 PACKAGING 110 13.2.1.1 Rigid packaging 110 13.2.1.1.1 High durability, tamper-resistance, lightweight, and low cost, to drive market 110 13.2.1.2 Flexible packaging 110 13.2.1.2.1 Replacement for petroleum-based plastics to drive market 110 13.2.1.3 Other packaging 111 13.2.2 FOOD SERVICES 111 13.2.2.1 Cups 111 13.2.2.1.1 Increasing use of biodegradable disposable products to drive market 111 13.2.2.2 Trays 111 13.2.2.2.1 Increasing demand for sustainable trays to drive market 111 13.2.2.3 Other food services 111 13.3 BIOMEDICAL 113 13.3.1 SUTURES 113 13.3.1.1 High tensile strength to drive market 113 13.3.2 DRUG RELEASE 113 13.3.2.1 Biocompatibility for drug carrier applications to drive market 113 13.3.3 OTHER BIOMEDICAL APPLICATIONS 114 13.4 AGRICULTURE 115 13.4.1 MULCH FILMS 115 13.4.1.1 Extensive use by farmers to drive market 115 13.4.2 PLANT POTS 115 13.4.2.1 Plant pots help during stages of plant growth 115 13.4.3 OTHER AGRICULTURAL APPLICATIONS 115 13.5 OTHER APPLICATIONS 117 13.5.1 WASTEWATER TREATMENT 117 13.5.2 COSMETICS 117 13.5.3 CHEMICAL ADDITIVES 117 13.5.4 3D PRINTING 117 14 PHA MARKET, BY REGION 120 14.1 INTRODUCTION 121 14.2 EUROPE 123 14.2.1 GERMANY 128 14.2.1.1 Advanced infrastructure for solid waste management to drive market 128 14.2.2 UK 128 14.2.2.1 Government’s aim to achieve zero-waste economy to drive market 128 14.2.3 FRANCE 129 14.2.3.1 Government’s initiatives for bio-based economy to drive market 129 14.2.4 ITALY 130 14.2.4.1 Demand for eco-friendly packaging solutions to drive market 130 14.3 NORTH AMERICA 131 14.3.1 US 135 14.3.1.1 Stringent guidelines regarding production, use, and disposal of plastics to drive market 135 14.3.2 CANADA 136 14.3.2.1 Proposed ban on single-use plastics to drive market 136 14.3.3 MEXICO 137 14.3.3.1 Government initiatives and international investments to drive market 137 14.4 ASIA PACIFIC 138 14.4.1 CHINA 142 14.4.1.1 Global and local PHA manufacturers to drive market 142 14.4.2 INDIA 143 14.4.2.1 Ban on non-biodegradable plastics to drive market 143 14.4.3 JAPAN 144 14.4.3.1 Biomass-based and biodegradable plastics to drive market 144 14.4.4 MALAYSIA 145 14.4.4.1 Fully automated biodegradable plastic from palm oil to drive market 145 14.4.5 SOUTH KOREA 145 14.4.5.1 High number of R&D establishments to drive market 145 14.5 REST OF THE WORLD 146 14.5.1 SOUTH AMERICA 150 14.5.1.1 Awareness of green economy to drive market 150 14.5.2 MIDDLE EAST & AFRICA 150 14.5.2.1 Growing biomedical industry to drive market 150 15 COMPETITIVE LANDSCAPE 152 15.1 INTRODUCTION 152 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 152 15.3 MARKET SHARE ANALYSIS, 2024 154 15.4 REVENUE ANALYSIS, 2020–2024 156 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 157 15.5.1 STARS 157 15.5.2 EMERGING LEADERS 157 15.5.3 PERVASIVE PLAYERS 157 15.5.4 PARTICIPANTS 157 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 159 15.5.5.1 Company footprint 159 15.5.5.2 Region footprint 160 15.5.5.3 Type footprint 161 15.5.5.4 Application footprint 162 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 163 15.6.1 PROGRESSIVE COMPANIES 163 15.6.2 RESPONSIVE COMPANIES 163 15.6.3 DYNAMIC COMPANIES 163 15.6.4 STARTING BLOCKS 163 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 164 15.6.5.1 Detailed list of key startups/SMEs 164 15.6.5.2 Competitive benchmarking of key startups/SMEs 165 15.7 BRAND COMPARISON ANALYSIS 165 15.8 COMPANY VALUATION AND FINANCIAL METRICS 166 15.9 COMPETITIVE SCENARIO 167 15.9.1 PRODUCT LAUNCHES 167 15.9.2 DEALS 168 15.9.3 EXPANSIONS 171 15.9.4 OTHER DEVELOPMENTS 172 16 `COMPANY PROFILES 173 16.1 KEY PLAYERS 173 16.1.1 TEKNOR APEX 173 16.1.1.1 Business overview 173 16.1.1.2 Products/Solutions/Services offered 173 16.1.1.3 Recent developments 174 16.1.1.3.1 Deals 174 16.1.1.4 MnM view 174 16.1.1.4.1 Key strengths 174 16.1.1.4.2 Strategic choices 174 16.1.1.4.3 Weaknesses and competitive threats 174 16.1.2 KANEKA CORPORATION 175 16.1.2.1 Business overview 175 16.1.2.2 Products/Solutions/Services offered 176 16.1.2.3 Recent developments 177 16.1.2.3.1 Deals 177 16.1.2.3.2 Expansions 177 16.1.2.4 MnM view 177 16.1.2.4.1 Key strengths 177 16.1.2.4.2 Strategic choices 178 16.1.2.4.3 Weaknesses and competitive threats 178 16.1.3 ECOMANN BIOTECHNOLOGY CO. LTD 179 16.1.3.1 Business overview 179 16.1.3.2 Products/Solutions/Services offered 179 16.1.3.3 MnM view 180 16.1.3.3.1 Right to win 180 16.1.3.3.2 Strategic choices 180 16.1.3.3.3 Weaknesses and competitive threats 180 16.1.4 RWDC INDUSTRIES 181 16.1.4.1 Business overview 181 16.1.4.2 Products/Solutions/Services offered 181 16.1.4.3 Recent developments 181 16.1.4.3.1 Deals 181 16.1.4.3.2 Other developments 182 16.1.4.4 MnM view 183 16.1.4.4.1 Key strengths 183 16.1.4.4.2 Strategic choices 183 16.1.4.4.3 Weaknesses and competitive threats 183 16.1.5 BLUEPHA CO, LTD. 184 16.1.5.1 Business overview 184 16.1.5.2 Products/Solutions/Services offered 184 16.1.5.3 Recent developments 185 16.1.5.3.1 Product launches 185 16.1.5.3.2 Deals 185 16.1.5.3.3 Expansions 186 16.1.5.4 MnM view 186 16.1.5.4.1 Key strengths 186 16.1.5.4.2 Strategic choices 186 16.1.5.4.3 Weaknesses and competitive threats 186 16.1.6 NEWLIGHT TECHNOLOGIES, INC. 187 16.1.6.1 Business overview 187 16.1.6.2 Products/Solutions/Services offered 187 16.1.6.3 Recent developments 187 16.1.6.3.1 Deals 187 16.1.6.3.2 Expansions 188 16.1.6.4 MnM view 189 16.1.6.4.1 Key strengths 189 16.1.6.4.2 Strategic choices 189 16.1.6.4.3 Weaknesses and competitive threats 189 16.1.7 NINGBO TIANAN BIOMATERIALS CO., LTD. 190 16.1.7.1 Business overview 190 16.1.7.2 Products/Solutions/Services offered 190 16.1.8 BIOMER 191 16.1.8.1 Business overview 191 16.1.8.2 Products/Solutions/Services offered 191 16.1.9 BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD 192 16.1.9.1 Business overview 192 16.1.9.2 Products/Solutions/Services offered 192 16.1.9.3 Recent developments 193 16.1.9.3.1 Deals 193 16.1.10 TERRAVERDAE BIOWORKS INC. 194 16.1.10.1 Business overview 194 16.1.10.2 Products/Solutions/Services offered 194 16.1.10.3 Recent developments 195 16.1.10.3.1 Product launches 195 16.1.10.3.2 Deals 195 16.1.10.3.3 Other developments 195 16.2 OTHER PLAYERS 196 16.2.1 CJ CHEILJEDANG CORP. 196 16.2.2 GENECIS BIOINDUSTRIES INC. 196 16.2.3 MANGO MATERIALS 197 16.2.4 COFCO 197 16.2.5 MEDPHA BIOSCIENCE CO., LTD. 198 16.2.6 PAQUES BIOMATERIALS B.V. 198 16.2.7 PRAJ INDUSTRIES 199 16.2.8 PHAXTEC, INC. 199 16.2.9 UNILONG INDUSTRY CO., LTD. 200 16.2.10 MAIP SRL 201 17 RESEARCH METHODOLOGY 202 17.1 RESEARCH DATA 202 17.1.1 SECONDARY DATA 203 17.1.1.1 Key data from secondary sources 203 17.1.2 PRIMARY DATA 203 17.1.2.1 Key data from primary sources 204 17.1.2.2 Key primary participants 204 17.1.2.3 Breakdown of primary interviews 205 17.1.2.4 Key industry insights 205 17.2 MARKET SIZE ESTIMATION 206 17.2.1 BOTTOM-UP APPROACH 206 17.2.2 TOP-DOWN APPROACH 208 17.3 GROWTH FORECAST 208 17.3.1 SUPPLY-SIDE ANALYSIS 208 17.3.2 DEMAND-SIDE ANALYSIS 209 17.4 DATA TRIANGULATION 210 17.5 FACTOR ANALYSIS 212 17.6 RESEARCH ASSUMPTIONS 212 17.7 RESEARCH LIMITATIONS 213 17.8 RISK ASSESSMENT 213 18 ADJACENT & RELATED MARKETS 214 18.1 INTRODUCTION 214 18.2 LIMITATION 214 18.3 BIOPLASTICS & BIOPOLYMERS MARKET 214 18.3.1 MARKET DEFINITION 214 18.3.2 MARKET OVERVIEW 214 18.4 BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION 215 18.4.1 EUROPE 215 18.4.2 NORTH AMERICA 216 18.4.3 ASIA PACIFIC 217 18.4.4 MIDDLE EAST & AFRICA 217 18.4.5 SOUTH AMERICA 218 19 APPENDIX 219 19.1 DISCUSSION GUIDE 219 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221 19.3 CUSTOMIZATION OPTIONS 223 19.4 RELATED REPORTS 223 19.5 AUTHOR DETAILS 224

圖表清單 List of Tables & Figures

TABLE 1 NORTH AMERICAN AND EUROPEAN UNION REGULATIONS 37 TABLE 2 CONVENTIONAL PLASTICS: HEALTH CONCERNS 40 TABLE 3 PHA MARKET: PORTER’S FIVE FORCES ANALYSIS 48 TABLE 4 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2021–2030 (USD BILLION) 48 TABLE 5 PHA MARKET: ROLE IN ECOSYSTEM 54 TABLE 6 AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG) 55 TABLE 7 AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025 (USD/KG) 56 TABLE 8 IMPORT DATA FOR HS CODE 391190-COMPLIANT PRODUCTS, 2020–2024 (USD MILLION) 57 TABLE 9 EXPORT DATA FOR HS CODE 391190-COMPLIANT PRODUCTS, 2020–2024 (USD MILLION) 58 TABLE 10 PHA MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 59 TABLE 11 PHA MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2025 60 TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 62 TABLE 13 PATENT STATUS: PATENT APPLICATIONS AND GRANTED PATENTS 70 TABLE 14 MAJOR PATENTS FOR PHA 72 TABLE 15 PATENTS BY KANEKA CORPORATION 73 TABLE 16 TOP 10 PATENT OWNERS IN US, 2014–2024 74 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 22 GLOBAL STANDARDS IN PHA MARKET 79 TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHA MARKET 81 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%) 83 TABLE 25 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84 TABLE 26 PHA MARKET: UNMET NEEDS IN KEY APPLICATIONS 85 TABLE 27 BACTERIUM STRAINS AND OUTPUT 90 TABLE 28 CURRENT PRODUCTION CAPACITIES (TON) 93 TABLE 29 UPCOMING PLAYERS 94 TABLE 30 DISCONTINUED OR STALLED PRODUCTION 95 TABLE 31 PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 97 TABLE 32 PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 98 TABLE 33 PHA MARKET, BY TYPE, 2020–2024 (TON) 98 TABLE 34 PHA MARKET, BY TYPE, 2025–2030 (TON) 98 TABLE 35 SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (USD MILLION) 99 TABLE 36 SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (USD MILLION) 100 TABLE 37 SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (TON) 100 TABLE 38 SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (TON) 100 TABLE 39 MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (USD MILLION) 101 TABLE 40 MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (USD MILLION) 102 TABLE 41 MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (TON) 102 TABLE 42 MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (TON) 102 TABLE 43 PHA MARKET, BY PRODUCTION METHOD, 2020–2024 (USD MILLION) 104 TABLE 44 PHA MARKET, BY PRODUCTION METHOD, 2025–2030 (USD MILLION) 104 TABLE 45 PHA MARKET, BY PRODUCTION METHOD, 2020–2024 (TON) 105 TABLE 46 PHA MARKET, BY PRODUCTION METHOD, 2025–2030 (TON) 105 TABLE 47 PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 108 TABLE 48 PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 109 TABLE 49 PHA MARKET, BY APPLICATION, 2020–2024 (TON) 109 TABLE 50 PHA MARKET, BY APPLICATION, 2025–2030 (TON) 109 TABLE 51 PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2020–2024 (USD MILLION) 112 TABLE 52 PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2025–2030 (USD MILLION) 112 TABLE 53 PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2020–2024 (TON) 112 TABLE 54 PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2025–2030 (TON) 113 TABLE 55 PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2020–2024 (USD MILLION) 114 TABLE 56 PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2025–2030 (USD MILLION) 114 TABLE 57 PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2020–2024 (TON) 114 TABLE 58 PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2025–2030 (TON) 115 TABLE 59 PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2020–2024 (USD MILLION) 116 TABLE 60 PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2025–2030 (USD MILLION) 116 TABLE 61 PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2020–2024 (TON) 116 TABLE 62 PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2025–2030 (TON) 117 TABLE 63 PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2020–2024 (USD MILLION) 118 TABLE 64 PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 118 TABLE 65 PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2020–2024 (TON) 118 TABLE 66 PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2025–2030 (TON) 119 TABLE 67 PHA MARKET, BY REGION, 2020–2024 (USD MILLION) 121 TABLE 68 PHA MARKET, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 69 PHA MARKET, BY REGION, 2020–2024 (TON) 122 TABLE 70 PHA MARKET, BY REGION, 2025–2030 (TON) 122 TABLE 71 EUROPE: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 124 TABLE 72 EUROPE: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 124 TABLE 73 EUROPE: PHA MARKET, BY TYPE, 2020–2024 (TON) 125 TABLE 74 EUROPE: PHA MARKET, BY TYPE, 2025–2030 (TON) 125 TABLE 75 EUROPE: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 125 TABLE 76 EUROPE: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 125 TABLE 77 EUROPE: PHA MARKET, BY APPLICATION, 2020–2024 (TON) 126 TABLE 78 EUROPE: PHA MARKET, BY APPLICATION, 2025–2030 (TON) 126 TABLE 79 EUROPE: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 126 TABLE 80 EUROPE: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 127 TABLE 81 EUROPE: PHA MARKET, BY COUNTRY, 2020–2024 (TON) 127 TABLE 82 EUROPE: PHA MARKET, BY COUNTRY, 2025–2030 (TON) 127 TABLE 83 GERMANY: PHA MARKET, 2020–2024 128 TABLE 84 GERMANY: PHA MARKET, 2025–2030 128 TABLE 85 UK: PHA MARKET, 2020–2024 129 TABLE 86 UK: PHA MARKET SIZE, 2025–2030 129 TABLE 87 FRANCE: PHA MARKET, 2020–2024 129 TABLE 88 FRANCE: PHA MARKET SIZE, 2025–2030 129 TABLE 89 ITALY: PHA MARKET, 2020–2024 130 TABLE 90 ITALY: PHA MARKET SIZE, 2025–2030 130 TABLE 91 NORTH AMERICA: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 132 TABLE 92 NORTH AMERICA: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 132 TABLE 93 NORTH AMERICA: PHA MARKET, BY TYPE, 2020–2024 (TON) 132 TABLE 94 NORTH AMERICA: PHA MARKET, BY TYPE, 2025–2030 (TON) 132 TABLE 95 NORTH AMERICA: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 133 TABLE 96 NORTH AMERICA: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 133 TABLE 97 NORTH AMERICA: PHA MARKET, BY APPLICATION, 2020–2024 (TON) 133 TABLE 98 NORTH AMERICA: PHA MARKET, BY APPLICATION, 2025–2030 (TON) 134 TABLE 99 NORTH AMERICA: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 134 TABLE 100 NORTH AMERICA: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 134 TABLE 101 NORTH AMERICA: PHA MARKET, BY COUNTRY, 2020–2024 (TON) 135 TABLE 102 NORTH AMERICA: PHA MARKET, BY COUNTRY, 2025–2030 (TON) 135 TABLE 103 US: PHA MARKET, 2020–2024 136 TABLE 104 US: PHA MARKET, 2025–2030 136 TABLE 105 CANADA: PHA MARKET, 2020–2024 136 TABLE 106 CANADA: PHA MARKET, 2025–2030 137 TABLE 107 MEXICO: PHA MARKET, 2020–2024 137 TABLE 108 MEXICO: PHA MARKET, 2025–2030 137 TABLE 109 ASIA PACIFIC: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 139 TABLE 110 ASIA PACIFIC: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 139 TABLE 111 ASIA PACIFIC: PHA MARKET, BY TYPE, 2020–2024 (TON) 139 TABLE 112 ASIA PACIFIC: PHA MARKET, BY TYPE, 2025–2030 (TON) 139 TABLE 113 ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 140 TABLE 114 ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 140 TABLE 115 ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2020–2024 (TON) 140 TABLE 116 ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2025–2030 (TON) 141 TABLE 117 ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 141 TABLE 118 ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 141 TABLE 119 ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2020–2024 (TON) 142 TABLE 120 ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2025–2030 (TON) 142 TABLE 121 CHINA: PHA MARKET, 2020–2024 143 TABLE 122 CHINA: PHA MARKET, 2025–2030 143 TABLE 123 INDIA: PHA MARKET, 2020–2024 143 TABLE 124 INDIA: PHA MARKET, 2025–2030 143 TABLE 125 JAPAN: PHA MARKET, 2020–2024 144 TABLE 126 JAPAN: PHA MARKET, 2025–2030 144 TABLE 127 MALAYSIA: PHA MARKET, 2020–2024 145 TABLE 128 MALAYSIA: PHA MARKET, 2025–2030 145 TABLE 129 SOUTH KOREA: PHA MARKET, 2020–2024 146 TABLE 130 SOUTH KOREA: PHA MARKET, 2025–2030 146 TABLE 131 REST OF THE WORLD: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 146 TABLE 132 REST OF THE WORLD: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 147 TABLE 133 REST OF THE WORLD: PHA MARKET, BY TYPE, 2020–2024 (TON) 147 TABLE 134 REST OF THE WORLD: PHA MARKET, BY TYPE, 2025–2030 (TON) 147 TABLE 135 REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 147 TABLE 136 REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 148 TABLE 137 REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2020–2024 (TON) 148 TABLE 138 REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2025–2030 (TON) 148 TABLE 139 REST OF THE WORLD: PHA MARKET, BY REGION, 2020–2024 (USD MILLION) 149 TABLE 140 REST OF THE WORLD: PHA MARKET, BY REGION, 2025–2030 (USD MILLION) 149 TABLE 141 REST OF THE WORLD: PHA MARKET, BY REGION, 2020–2024 (TON) 149 TABLE 142 REST OF THE WORLD: PHA MARKET, BY REGION, 2025–2030 (TON) 149 TABLE 143 SOUTH AMERICA: PHA MARKET, 2020–2024 150 TABLE 144 SOUTH AMERICA: PHA MARKET, 2025–2030 150 TABLE 145 MIDDLE EAST & AFRICA: PHA MARKET, 2020–2024 151 TABLE 146 MIDDLE EAST & AFRICA: PHA MARKET, 2025–2030 151 TABLE 147 PHA MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURERS, JANUARY 2020–SEPTEMBER 2025 152 TABLE 148 PHA MARKET: DEGREE OF COMPETITION, 2024 154 TABLE 149 PHA MARKET: REGION FOOTPRINT 160 TABLE 150 PHA MARKET: TYPE FOOTPRINT 161 TABLE 151 PHA MARKET: APPLICATION FOOTPRINT 162 TABLE 152 PHA MARKET: DETAILED LIST OF KEY STARTUPS/SMES 164 TABLE 153 PHA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 165 TABLE 154 PHA MARKET: PRODUCT LAUNCHES, JANUARY 2020–SEPTEMBER 2025 167 TABLE 155 PHA MARKET: DEALS, JANUARY 2020– SEPTEMBER 2025 168 TABLE 156 PHA MARKET: EXPANSIONS, JANUARY 2020– SEPTEMBER 2025 171 TABLE 157 PHA MARKET: OTHER DEVELOPMENTS, JANUARY 2020–SEPTEMBER 2025 172 TABLE 158 TEKNOR APEX: COMPANY OVERVIEW 173 TABLE 159 TEKNOR APEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED 173 TABLE 160 TEKNOR APEX: DEALS 174 TABLE 161 KANEKA CORPORATION: COMPANY OVERVIEW 175 TABLE 162 KANEKA CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 176 TABLE 163 KANEKA CORPORATION: DEALS 177 TABLE 164 KANEKA CORPORATION: EXPANSIONS 177 TABLE 165 ECOMANN BIOTECHNOLOGY CO. LTD: COMPANY OVERVIEW 179 TABLE 166 ECOMANN BIOTECHNOLOGY CO. LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 179 TABLE 167 RWDC INDUSTRIES: COMPANY OVERVIEW 181 TABLE 168 RWDC INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 181 TABLE 169 RWDC INDUSTRIES: DEALS 181 TABLE 170 RWDC INDUSTRIES: OTHER DEVELOPMENTS 182 TABLE 171 BLUEPHA CO. LTD.: COMPANY OVERVIEW 184 TABLE 172 BLUEPHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184 TABLE 173 BLUEPHA CO. LTD.: PRODUCT LAUNCHES 185 TABLE 174 BLUEPHA CO. LTD.: DEALS 185 TABLE 175 BLUEPHA CO. LTD.: EXPANSIONS 186 TABLE 176 NEWLIGHT TECHNOLOGIES, INC.: COMPANY OVERVIEW 187 TABLE 177 NEWLIGHT TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187 TABLE 178 NEWLIGHT TECHNOLOGIES, INC.: DEALS 187 TABLE 179 NEWLIGHT TECHNOLOGIES: EXPANSIONS 188 TABLE 180 NINGBO TIANAN BIOMATERIALS CO., LTD.: COMPANY OVERVIEW 190 TABLE 181 NINGBO TIANAN BIOMATERIALS CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED 190 TABLE 182 BIOMER: COMPANY OVERVIEW 191 TABLE 183 BIOMER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 191 TABLE 184 BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: COMPANY OVERVIEW 192 TABLE 185 BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: PRODUCTS/SOLUTIONS/ SERVICES OFFERED 192 TABLE 186 BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: DEALS 193 TABLE 187 TERRAVERDAE BIOWORKS INC.: COMPANY OVERVIEW 194 TABLE 188 TERRAVERDAE BIOWORKS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 194 TABLE 189 TERRAVERDAE BIOWORKS INC.: PRODUCT LAUNCHES 195 TABLE 190 TERRAVERDAE BIOWORKS INC.: DEALS 195 TABLE 191 TERRAVERDAE BIOWORKS INC.: OTHER DEVELOPMENTS 195 TABLE 192 CJ CHEILJEDANG CORP.: COMPANY OVERVIEW 196 TABLE 193 GENECIS BIOINDUSTRIES INC.: COMPANY OVERVIEW 196 TABLE 194 MANGO MATERIALS: COMPANY OVERVIEW 197 TABLE 195 COFCO: COMPANY OVERVIEW 197 TABLE 196 MEDPHA BIOSCIENCE CO., LTD.: COMPANY OVERVIEW 198 TABLE 197 PAQUES BIOMATERIALS B.V.: COMPANY OVERVIEW 198 TABLE 198 PRAJ INDUSTRIES: COMPANY OVERVIEW 199 TABLE 199 PHAXTEC, INC.: COMPANY OVERVIEW 199 TABLE 200 UNILONG INDUSTRY CO., LTD.: COMPANY OVERVIEW 200 TABLE 201 MAIP SRL: COMPANY OVERVIEW 201 TABLE 202 PHA MARKET: RISK ASSESSMENT 213 TABLE 203 BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION, 2019–2023 (USD MILLION) 215 TABLE 204 BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION, 2024–2029 (USD MILLION) 215 TABLE 205 EUROPE: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 215 TABLE 206 EUROPE: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 216 TABLE 207 NORTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 216 TABLE 208 NORTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 216 TABLE 209 ASIA PACIFIC: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 217 TABLE 210 ASIA PACIFIC: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 217 TABLE 211 MIDDLE EAST & AFRICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 217 TABLE 212 MIDDLE EAST & AFRICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 218 TABLE 213 SOUTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 218 TABLE 214 SOUTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 218 FIGURE 1 PHA MARKET SEGMENTATION AND REGIONAL SCOPE 23 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 28 FIGURE 3 GLOBAL PHA MARKET, 2025–2030 28 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHA MARKET (2020–2025) 29 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHA MARKET 30 FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHA MARKET, 2024 30 FIGURE 7 EUROPE TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 31 FIGURE 8 HIGH DEMAND FROM PACKAGING & FOOD SERVICES APPLICATIONS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 33 FIGURE 9 PACKAGING & FOOD SERVICES APPLICATION ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 34 FIGURE 10 SHORT CHAIN LENGTH SEGMENT DOMINATED PHA MARKET IN 2024 34 FIGURE 11 ITALY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35 FIGURE 12 PHA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36 FIGURE 13 SHORTCOMINGS OF NON-BIODEGRADABLE WASTE DISPOSAL METHODS 39 FIGURE 14 PHA MARKET: PORTER’S FIVE FORCES ANALYSIS 46 FIGURE 15 PHA MARKET: SUPPLY CHAIN ANALYSIS 51 FIGURE 16 PHA MARKET: KEY PARTICIPANTS IN ECOSYSTEM 53 FIGURE 17 PHA MARKET: ECOSYSTEM ANALYSIS 53 FIGURE 18 AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 55 FIGURE 19 AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025 56 FIGURE 20 IMPORT SCENARIO FOR HS CODE 391190-COMPLIANT PRODUCTS, BY KEY COUNTRIES, 2020–2024 57 FIGURE 21 EXPORT SCENARIO FOR HS CODE 391190-COMPLIANT PRODUCTS, BY KEY COUNTRIES, 2020–2024 58 FIGURE 22 TREND/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 60 FIGURE 23 PATENTS REGISTERED, 2014–2024 71 FIGURE 24 LIST OF MAJOR PATENTS FOR PHA 71 FIGURE 25 LEGAL STATUS OF PATENTS FILED IN PHA MARKET 74 FIGURE 26 MAXIMUM PATENTS FILED IN JURISDICTION OF US 75 FIGURE 27 IMPACT OF AI/GEN AI ON PHA MARKET 75 FIGURE 28 PHA MARKET: DECISION-MAKING FACTORS 82 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 83 FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84 FIGURE 31 ADOPTION BARRIERS & INTERNAL CHALLENGES 85 FIGURE 32 PROCESS FLOW OF PHA PRODUCTION 87 FIGURE 33 SUGAR SUBSTRATES FOR PHA PRODUCTION 88 FIGURE 34 HYDROCARBON SUBSTRATES 89 FIGURE 35 EXTRACTION PROCESS FLOW 92 FIGURE 36 SHORT CHAIN LENGTH SEGMENT TO HOLD LARGEST SHARE OF PHA MARKET IN 2025 97 FIGURE 37 SUGAR FERMENTATION SEGMENT TO HOLD LARGEST SHARE OF PHA MARKET DURING FORECAST PERIOD 104 FIGURE 38 PACKAGING & FOOD SERVICES TO DOMINATE PHA MARKET DURING FORECAST PERIOD 108 FIGURE 39 EUROPE TO LEAD PHA MARKET BETWEEN 2025 AND 2030 121 FIGURE 40 EUROPE: PHA MARKET SNAPSHOT 124 FIGURE 41 NORTH AMERICA: PHA MARKET SNAPSHOT 131 FIGURE 42 ASIA PACIFIC: PHA MARKET SNAPSHOT 138 FIGURE 43 PHA MARKET SHARE ANALYSIS, 2024 154 FIGURE 44 PHA MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD MILLION) 156 FIGURE 45 PHA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 158 FIGURE 46 PHA MARKET: COMPANY FOOTPRINT 159 FIGURE 47 PHA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 164 FIGURE 48 PHA MARKET: BRAND COMPARISON 165 FIGURE 49 PHA MARKET: EV/EBITDA OF KEY MANUFACTURERS 166 FIGURE 50 PHA MARKET: ENTERPRISE VALUATION (EV) OF KEY PLAYERS (USD BILLION) 167 FIGURE 51 KANEKA CORPORATION: COMPANY SNAPSHOT 176 FIGURE 52 PHA MARKET: RESEARCH DESIGN 202 FIGURE 53 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE): COLLECTIVE MARKET SHARE OF KEY PLAYERS 206 FIGURE 54 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 - BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF ALL PRODUCTS 207 FIGURE 55 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 - BOTTOM-UP (DEMAND SIDE) 207 FIGURE 56 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 - TOP-DOWN 208 FIGURE 57 MARKET CAGR PROJECTIONS FROM SUPPLY SIDE 209 FIGURE 58 MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS AND OPPORTUNITIES 210 FIGURE 59 PHA MARKET: DATA TRIANGULATION 211

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Polyhydroxyalkanoate (PHA) Market by Type (Short Chain Length, Medium Chain Length), Production Method (Sugar Fermentation, Vegetable Oil Fermentation), Application (Packaging & Food Services, Biomedical), and Region - Global Forecasts to 2030

授權報價

報告摘要

同分類最新報告（化學與材料）